AI-Powered Technology:
PGxAI harnesses cutting-edge AI capabilities, enabling instantaneous analysis of pharmacogenetic data for the first time. This ensures rapid and accurate results tailored to individual needs.
Enabling Safe & Efficient Drug Therapy Based On The Results Of Genetic Testing
Get To Know UsPrecision Treatment Tuned with Advanced Technologies
Explore ServicesAdvanced Solutions for Pharmacogenetic Data Analysis
More About TechnologyProfessionalism and Innovation in Every Aspect of Our Work
About Us
Welcome to PGxAI, a company at the forefront of scientific research and innovation in the field of pharmacogenetics. Our mission is to harness genetic data to craft personalized medical solutions, ensuring the most effective and safest treatments for patients.
Our team is a unique blend of scientists, engineers, medical professionals, and entrepreneurs, all united by a single goal: to transform modern healthcare through cutting-edge technologies. Each member of our team is an expert in their respective field, and together, we are dedicated to creating solutions that can change lives.
AI-Powered Technology:
PGxAI harnesses cutting-edge AI capabilities, enabling instantaneous analysis of pharmacogenetic data for the first time. This ensures rapid and accurate results tailored to individual needs.
Extensive Drug Database:
Our platform boasts the largest drug database across all clinical specialties, encompassing over 730 medications. This vast range ensures comprehensive analysis catering to diverse patient requirements.
Cost-Effective Analysis:
At a rate of approximately $0.055 per drug analysis, PGxAI offers unparalleled value, making our services significantly more affordable compared to competitors.
Holistic Drug Interaction Analysis:
Beyond individual drug assessments, PGxAI provides an in-depth drug interaction analysis, identifying potential risks associated with combined medication intake (drug-drug interaction checker). Additionally, our platform can pinpoint health risks such as thrombosis and atherosclerosis, positioning PGxAI not just as a drug analysis tool, but a vital health assessment instrument.
Our search in the realm of personalized medicine is a harmonious blend of clinical pharmacology, genetics and cutting-edge technology. Here's a glimpse into our process:
Join us in our mission to redefine healthcare, making it more personalized, effective, and forward-thinking.
Executive Chairman & Co-Founder
Venture Investor, 5 NASDAQ IPOs + 4 M&As
Executive Chairman & Co-Founder
Venture Investor, 5 NASDAQ IPOs + 4 M&As
CEO & Co-Founder
MD PhD, Bioengineering and Therapeutical Sciences at UCSF
CEO & Co-Founder
MD PhD, Bioengineering and Therapeutical Sciences at UCSF
VP of Business
Neuroscience and Finance at Stanford
VP of Business
Neuroscience and Finance at Stanford
VP of Development
Architect, Product Manager at Intel
VP of Development
Architect, Product Manager at Intel
International Partner
DDS - MSc
International Partner
DDS - MSc
Scientific Advisor
Senior Director at Thermo Fisher Precision Medicine Science Center
Scientific Advisor
Senior Director at Thermo Fisher Precision Medicine Science Center
Scientific Advisor
Senior Medical Science Liaison at Tempus Labs
Scientific Advisor
Senior Medical Science Liaison at Tempus Labs
Scientific Advisor
Chief Scientific Officer at Spectrum Solutions
Scientific Advisor
Chief Scientific Officer at Spectrum Solutions
Business Advisor
Senior Director Clinical Affairs at Abbott
Business Advisor
Senior Director Clinical Affairs at Abbott
Business Advisor
Ex-Director Innovation, Strategy & Product at GE Healthcare
Business Advisor
Ex-Director Innovation, Strategy & Product at GE Healthcare
Data Scientists
Bioinformatician
Million Potential Donors
Second Change Life
PGxAI, a pioneering force in the realm of pharmacogenomics, is thrilled to announce a significant leap forward in our quest to revolutionize personalized medicine.
As PGxAI descended upon Orlando, Florida, for the highly anticipated HIMSS2024 conference
Building on the excitement of our recent achievements, PGxAI is thrilled to share two groundbreaking developments that mark a significant milestone in our journey towards…
This breakthrough in pharmacogenetics promises to radically change treatment approaches, making them more personalized and safer for each patient.
We're extremely excited to announce that #PGxAI has been selected to participate in the prestigious #HIMSS2024 conference in Orlando
In a monumental stride for personalized medicine, PGxAI has unveiled its advanced AI algorithm designed to optimize drug therapy based on individual genetics. This innova…
Pharmacogenetic analyses provide insights into specific DNA variations that can impact drug interactions by elucidating how particular DNA changes may affect enzyme efficiency in drug metabolism, while recognizing that other factors, such as age, body mass, liver and kidney health, concurrent medications, and lifestyle choices, also contribute.
PREV